Medication info

Rozaduo Tablet 10/50mg

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Amlodipine Besylate›13.888mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
Pink rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201905578 · Approved 2019.08.07

This product's status changed to Approval withdrawn on 2024.02.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Initial treatment of essential hypertension and stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning), if possible. It is recommended that the doses of the individual components (amlodipine or losartan) be adjusted before administering this medicine; however, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination product compared with monotherapy. Usually, this medicine is administered at 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced effective circulating blood volume: Administration of this medicine is not recommended in a small number of patients with intravascular volume depletion (e.g., patients being treated with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In patients aged 75 years and older, an initial dose of losartan of 25 mg once daily is recommended; therefore, administration of this medicine as initial therapy is not recommended.
Child dose
○ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Initial treatment of essential hypertension and stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used when blood pressure is not adequately controlled by monotherapy with amlodipine or losartan in patients with essential hypertension. It is also effective in initial treatment for stage 2 hypertension patients who require combination therapy to reach the target blood pressure. Thus, it helps to manage blood pressure reliably.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning), if possible. It is recommended that the doses of the individual components (amlodipine or losartan) be adjusted before administering this medicine; however, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination product compared with monotherapy. Usually, this medicine is administered at 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced effective circulating blood volume: Administration of this medicine is not recommended in a small number of patients with intravascular volume depletion (e.g., patients being treated with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In patients aged 75 years and older, an initial dose of losartan of 25 mg once daily is recommended; therefore, administration of this medicine as initial therapy is not recommended.

Child dose

○ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus, particularly when taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Various issues related to decreased renal function in the fetus may arise during pregnancy, so it should not be taken by women who may become pregnant. Patients with reduced intravascular blood volume, especially those on diuretics, may experience symptoms of hypotension when starting this medication, so caution is required. This medication should not be administered to patients with hypersensitivity to certain components, women who are pregnant or breastfeeding, patients with severe liver dysfunction, patients with severe aortic stenosis, or patients in a state of shock. Caution must be exercised when administering to patients with reduced intravascular blood volume or those on strict sodium restrictions, patients with moderate to severe renal impairment, and patients with hyperkalemia. Symptoms such as dizziness or headache may commonly occur when taking this medication, so caution is advised when engaging in hazardous activities such as working at heights or driving. This medication may affect liver and kidney functions, so patients with liver or kidney disease should have their condition regularly monitored. When used with other antihypertensive agents, the blood pressure-lowering effect may be increased, so it should be taken according to a physician's instructions. Taking with grapefruit juice may increase drug concentration, so concurrent use should be avoided. It is recommended that women who are pregnant or breastfeeding not take this medication to ensure the safety of the fetus and newborn. Safety and efficacy in patients under 18 years of age have not been established, and thus its use is not recommended. In case of overdose, severe hypotension and cardiac dysfunction may occur, and immediate medical attention should be sought.

Side effects

Dizziness, headache, sedation, cerebral infarction, weakness, chest discomfort, chest pain, early satiety, peripheral edema, pitting edema, abdominal discomfort, dyspepsia, nausea, gastroesophageal reflux disease, constipation, pruritus, urticaria, palpitations, flushing, orthostatic hypotension, facial flushing, dyspnea, cough, eye redness, increased urinary frequency, fatigue, edema, vertigo, abdominal pain, weakness, lethargy, pain, weight gain, weight loss, hypotension, vasculitis, increased tension, sensory decrease, sensory abnormality, peripheral neuropathy, syncope, taste abnormality, tremor, erectile dysfunction, gynecomastia, change in bowel habits, dry mouth, gastritis, gingival hypertrophy, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, insomnia, mood changes, cough, rhinitis, hair loss, increased sweating, purpura, skin discoloration, urticaria, tinnitus, visual disturbances, increased urinary frequency, urinary disorders, nocturnal enuresis, hepatitis, jaundice, elevated liver enzymes, pruritus, rash, angioedema, erythema multiforme, myocardial infarction, arrhythmia, blood pressure decrease, sinoatrial block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, skin erythema, maculopapular rash, heaviness, burning sensation, impaired glucose tolerance, weakness, muscle spasm, low back pain, leg pain, congestion, upper respiratory infection, sinusitis, diarrhea, sinus disorder, pharyngitis, myalgia, insomnia, bloating, abdominal pain, angioedema, skin desquamation, hemolysis, facial edema, fever, orthostatic effect, syncope, angina, second-degree atrioventricular block, cerebrovascular accident, hypotension, myocardial infarction, atrial fibrillation, tachycardia, ventricular tachycardia, ventricular fibrillation, loss of appetite, toothache, flatulence, gastritis, anemia, gout, upper limb pain, hip pain, joint swelling, knee pain, musculoskeletal pain, shoulder pain, muscle stiffness, arthralgia, arthritis, fibromyalgia, myasthenia, anxiety, anxiety disorder, ataxia, confusion, depression, nightmares, sensory decline, decreased libido, memory impairment, migraine, neuroexcitability, panic disorder, sleep disorder, tremor, bronchitis, pharyngeal discomfort, epistaxis, rhinitis, respiratory congestion, hair loss, dermatitis, dry skin, petechiae, erythema, photosensitivity, itching, rash, sweating, urticaria, blurred vision, burning sensation and pain in the eyes, conjunctivitis, taste distortion, tinnitus, decreased vision, erectile dysfunction, nocturnal enuresis, urethral infection, dry cough, angioedema, vasculitis, anaphylactic reaction, liver dysfunction, lethargy, thrombocytopenia, rhabdomyolysis, taste abnormality, erythroderma, hyperkalemia, hyponatremia, increased ALT, increased serum creatinine, elevated liver enzymes or serum bilirubin, syncope, loss of consciousness, acute hepatitis, fulminant hepatitis, anaphylactoid syndrome, excessive peripheral vasodilation, reflex tachycardia, systemic hypotension, shock, hypotension, tachycardia, bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.